ZOETIS INC (ZOE.DE) Fundamental Analysis & Valuation
FRA:ZOE • US98978V1035
Current stock price
98.58 EUR
-1.77 (-1.76%)
Last:
This ZOE.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ZOE.DE Profitability Analysis
1.1 Basic Checks
- In the past year ZOE was profitable.
- In the past year ZOE had a positive cash flow from operations.
- In the past 5 years ZOE has always been profitable.
- In the past 5 years ZOE always reported a positive cash flow from operatings.
1.2 Ratios
- ZOE has a Return On Assets of 17.28%. This is amongst the best in the industry. ZOE outperforms 93.88% of its industry peers.
- The Return On Equity of ZOE (80.25%) is better than 100.00% of its industry peers.
- With an excellent Return On Invested Capital value of 21.95%, ZOE belongs to the best of the industry, outperforming 89.80% of the companies in the same industry.
- ZOE had an Average Return On Invested Capital over the past 3 years of 22.23%. This is significantly above the industry average of 14.21%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.28% | ||
| ROE | 80.25% | ||
| ROIC | 21.95% |
ROA(3y)17.05%
ROA(5y)15.99%
ROE(3y)59.76%
ROE(5y)54.42%
ROIC(3y)22.23%
ROIC(5y)21.04%
1.3 Margins
- Looking at the Profit Margin, with a value of 28.23%, ZOE belongs to the top of the industry, outperforming 91.84% of the companies in the same industry.
- In the last couple of years the Profit Margin of ZOE has grown nicely.
- The Operating Margin of ZOE (38.54%) is better than 93.88% of its industry peers.
- In the last couple of years the Operating Margin of ZOE has grown nicely.
- ZOE has a Gross Margin (71.89%) which is comparable to the rest of the industry.
- In the last couple of years the Gross Margin of ZOE has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 38.54% | ||
| PM (TTM) | 28.23% | ||
| GM | 71.89% |
OM growth 3Y1.57%
OM growth 5Y2.33%
PM growth 3Y2.57%
PM growth 5Y2.85%
GM growth 3Y1.04%
GM growth 5Y0.73%
2. ZOE.DE Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ZOE is creating value.
- The number of shares outstanding for ZOE has been reduced compared to 1 year ago.
- Compared to 5 years ago, ZOE has less shares outstanding
- Compared to 1 year ago, ZOE has a worse debt to assets ratio.
2.2 Solvency
- ZOE has an Altman-Z score of 5.42. This indicates that ZOE is financially healthy and has little risk of bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 5.42, ZOE belongs to the top of the industry, outperforming 83.67% of the companies in the same industry.
- ZOE has a debt to FCF ratio of 3.96. This is a good value and a sign of high solvency as ZOE would need 3.96 years to pay back of all of its debts.
- ZOE has a Debt to FCF ratio (3.96) which is comparable to the rest of the industry.
- ZOE has a Debt/Equity ratio of 2.71. This is a high value indicating a heavy dependency on external financing.
- ZOE has a worse Debt to Equity ratio (2.71) than 81.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.71 | ||
| Debt/FCF | 3.96 | ||
| Altman-Z | 5.42 |
ROIC/WACC2.39
WACC9.18%
2.3 Liquidity
- A Current Ratio of 3.03 indicates that ZOE has no problem at all paying its short term obligations.
- With an excellent Current ratio value of 3.03, ZOE belongs to the best of the industry, outperforming 89.80% of the companies in the same industry.
- A Quick Ratio of 1.94 indicates that ZOE should not have too much problems paying its short term obligations.
- ZOE's Quick ratio of 1.94 is amongst the best of the industry. ZOE outperforms 87.76% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.03 | ||
| Quick Ratio | 1.94 |
3. ZOE.DE Growth Analysis
3.1 Past
- ZOE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.45%, which is quite good.
- Measured over the past years, ZOE shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.77% on average per year.
- Looking at the last year, ZOE shows a small growth in Revenue. The Revenue has grown by 2.28% in the last year.
- The Revenue has been growing slightly by 7.24% on average over the past years.
EPS 1Y (TTM)8.45%
EPS 3Y9.57%
EPS 5Y10.77%
EPS Q2Q%5.71%
Revenue 1Y (TTM)2.28%
Revenue growth 3Y5.42%
Revenue growth 5Y7.24%
Sales Q2Q%3.02%
3.2 Future
- The Earnings Per Share is expected to grow by 7.84% on average over the next years.
- Based on estimates for the next years, ZOE will show a small growth in Revenue. The Revenue will grow by 4.92% on average per year.
EPS Next Y10.17%
EPS Next 2Y8.84%
EPS Next 3Y8.56%
EPS Next 5Y7.84%
Revenue Next Year4.85%
Revenue Next 2Y4.81%
Revenue Next 3Y4.79%
Revenue Next 5Y4.92%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. ZOE.DE Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 17.92, which indicates a rather expensive current valuation of ZOE.
- ZOE's Price/Earnings ratio is in line with the industry average.
- The average S&P500 Price/Earnings ratio is at 26.54. ZOE is valued slightly cheaper when compared to this.
- ZOE is valuated correctly with a Price/Forward Earnings ratio of 16.28.
- Based on the Price/Forward Earnings ratio, ZOE is valued a bit cheaper than the industry average as 61.22% of the companies are valued more expensively.
- The average S&P500 Price/Forward Earnings ratio is at 21.68. ZOE is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.92 | ||
| Fwd PE | 16.28 |
4.2 Price Multiples
- ZOE's Enterprise Value to EBITDA is on the same level as the industry average.
- ZOE's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.21 | ||
| EV/EBITDA | 13.54 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The excellent profitability rating of ZOE may justify a higher PE ratio.
PEG (NY)1.76
PEG (5Y)1.66
EPS Next 2Y8.84%
EPS Next 3Y8.56%
5. ZOE.DE Dividend Analysis
5.1 Amount
- ZOE has a Yearly Dividend Yield of 1.64%. Purely for dividend investing, there may be better candidates out there.
- Compared to an average industry Dividend Yield of 1.96, ZOE has a dividend in line with its industry peers.
- ZOE's Dividend Yield is comparable with the S&P500 average which is at 1.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.64% |
5.2 History
- On average, the dividend of ZOE grows each year by 20.56%, which is quite nice.
Dividend Growth(5Y)20.56%
Div Incr Years5
Div Non Decr Years5
5.3 Sustainability
- 33.26% of the earnings are spent on dividend by ZOE. This is a low number and sustainable payout ratio.
- ZOE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP33.26%
EPS Next 2Y8.84%
EPS Next 3Y8.56%
ZOE.DE Fundamentals: All Metrics, Ratios and Statistics
FRA:ZOE (4/29/2026, 3:42:40 PM)
98.58
-1.77 (-1.76%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Industry Strength65.84
Industry Growth15.53
Earnings (Last)02-12 2026-02-12/bmo
Earnings (Next)05-07 2026-05-07/bmo
Inst Owners101.23%
Inst Owner ChangeN/A
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap41.45B
Revenue(TTM)9.47B
Net Income(TTM)2.67B
Analysts76.8
Price Target127.45 (29.29%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.64% |
Yearly Dividend1.74
Dividend Growth(5Y)20.56%
DP33.26%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.16%
Min EPS beat(2)3.79%
Max EPS beat(2)4.53%
EPS beat(4)4
Avg EPS beat(4)5.31%
Min EPS beat(4)3.79%
Max EPS beat(4)7.75%
EPS beat(8)8
Avg EPS beat(8)4.82%
EPS beat(12)10
Avg EPS beat(12)3.31%
EPS beat(16)12
Avg EPS beat(16)3.06%
Revenue beat(2)1
Avg Revenue beat(2)-0.66%
Min Revenue beat(2)-1.44%
Max Revenue beat(2)0.13%
Revenue beat(4)3
Avg Revenue beat(4)0.04%
Min Revenue beat(4)-1.44%
Max Revenue beat(4)1.11%
Revenue beat(8)6
Avg Revenue beat(8)0.76%
Revenue beat(12)6
Avg Revenue beat(12)0.17%
Revenue beat(16)7
Avg Revenue beat(16)-0.2%
PT rev (1m)-3.48%
PT rev (3m)-9.59%
EPS NQ rev (1m)0.01%
EPS NQ rev (3m)2.62%
EPS NY rev (1m)-0.07%
EPS NY rev (3m)3.23%
Revenue NQ rev (1m)0.04%
Revenue NQ rev (3m)-0.21%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-0.08%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.92 | ||
| Fwd PE | 16.28 | ||
| P/S | 5.11 | ||
| P/FCF | 21.21 | ||
| P/OCF | 16.67 | ||
| P/B | 14.54 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.54 |
EPS(TTM)5.5
EY5.58%
EPS(NY)6.06
Fwd EY6.14%
FCF(TTM)4.65
FCFY4.72%
OCF(TTM)5.91
OCFY6%
SpS19.27
BVpS6.78
TBVpS-0.88
PEG (NY)1.76
PEG (5Y)1.66
Graham Number28.9698 (-70.61%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.28% | ||
| ROE | 80.25% | ||
| ROCE | 27.58% | ||
| ROIC | 21.95% | ||
| ROICexc | 26.6% | ||
| ROICexgc | 40.59% | ||
| OM | 38.54% | ||
| PM (TTM) | 28.23% | ||
| GM | 71.89% | ||
| FCFM | 24.12% |
ROA(3y)17.05%
ROA(5y)15.99%
ROE(3y)59.76%
ROE(5y)54.42%
ROIC(3y)22.23%
ROIC(5y)21.04%
ROICexc(3y)26.94%
ROICexc(5y)27.11%
ROICexgc(3y)44.63%
ROICexgc(5y)48.4%
ROCE(3y)27.92%
ROCE(5y)26.43%
ROICexgc growth 3Y-11.38%
ROICexgc growth 5Y-5.24%
ROICexc growth 3Y-2.74%
ROICexc growth 5Y2.7%
OM growth 3Y1.57%
OM growth 5Y2.33%
PM growth 3Y2.57%
PM growth 5Y2.85%
GM growth 3Y1.04%
GM growth 5Y0.73%
F-Score6
Asset Turnover0.61
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.71 | ||
| Debt/FCF | 3.96 | ||
| Debt/EBITDA | 2.19 | ||
| Cap/Depr | 127.52% | ||
| Cap/Sales | 6.56% | ||
| Interest Coverage | 13.98 | ||
| Cash Conversion | 70.21% | ||
| Profit Quality | 85.41% | ||
| Current Ratio | 3.03 | ||
| Quick Ratio | 1.94 | ||
| Altman-Z | 5.42 |
F-Score6
WACC9.18%
ROIC/WACC2.39
Cap/Depr(3y)136.13%
Cap/Depr(5y)128.18%
Cap/Sales(3y)7.4%
Cap/Sales(5y)7.12%
Profit Quality(3y)82.33%
Profit Quality(5y)78.99%
High Growth Momentum
Growth
EPS 1Y (TTM)8.45%
EPS 3Y9.57%
EPS 5Y10.77%
EPS Q2Q%5.71%
EPS Next Y10.17%
EPS Next 2Y8.84%
EPS Next 3Y8.56%
EPS Next 5Y7.84%
Revenue 1Y (TTM)2.28%
Revenue growth 3Y5.42%
Revenue growth 5Y7.24%
Sales Q2Q%3.02%
Revenue Next Year4.85%
Revenue Next 2Y4.81%
Revenue Next 3Y4.79%
Revenue Next 5Y4.92%
EBIT growth 1Y7.54%
EBIT growth 3Y7.08%
EBIT growth 5Y9.74%
EBIT Next Year18.61%
EBIT Next 3Y9.66%
EBIT Next 5Y7.88%
FCF growth 1Y-0.65%
FCF growth 3Y19.85%
FCF growth 5Y6.41%
OCF growth 1Y-1.66%
OCF growth 3Y14.95%
OCF growth 5Y6.44%
ZOETIS INC / ZOE.DE Fundamental Analysis FAQ
What is the fundamental rating for ZOE stock?
ChartMill assigns a fundamental rating of 6 / 10 to ZOE.DE.
What is the valuation status for ZOE stock?
ChartMill assigns a valuation rating of 4 / 10 to ZOETIS INC (ZOE.DE). This can be considered as Fairly Valued.
How profitable is ZOETIS INC (ZOE.DE) stock?
ZOETIS INC (ZOE.DE) has a profitability rating of 8 / 10.
Can you provide the financial health for ZOE stock?
The financial health rating of ZOETIS INC (ZOE.DE) is 7 / 10.
What is the earnings growth outlook for ZOETIS INC?
The Earnings per Share (EPS) of ZOETIS INC (ZOE.DE) is expected to grow by 10.17% in the next year.